SCM
PALI icon

Soleus Capital Management’s Palisade Bio PALI Stock Holding History

Soleus Capital Management’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
+13,063,687
New +$25.7M 0.94% 31

Other funds holding PALI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Soleus Capital Management's PALI Position: Q2 2026 in Review

Soleus Capital Management opened a new position in Palisade Bio (PALI) in Q2 2026: 13,063,687 shares worth $27.3M. The stake represents 0.94% of the portfolio and ranks #31 among its holdings.

71 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Soleus Capital Management held 13,063,687 shares of Palisade Bio worth $27.3M as of Q2 2026.
  • Palisade Bio was a new Soleus Capital Management position in Q2 2026.
  • Palisade Bio made up 0.94% of Soleus Capital Management's portfolio in Q2 2026, its #31 holding.
  • 71 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.